We can’t show the full text here under this license.
Better targeted mRNA delivery using lipid nanoparticles with a new synthetic cholesterol
Updated
Abstract
Essence
improved localized mRNA transfection while reducing liver transfection in cell and mouse tumor models.
Evidence
Formulation and preclinical platform experiments tested GA-Chol LNPs in HEK293T and HeLa cells, multiple cancer cell lines, intramuscular and intratumoral mouse delivery, and 4T1 tumor-bearing BALB/c mice.
Caveat
The findings are limited to in vitro systems and mouse models, including an intratumoral constitutively active caspase-3 mRNA payload, without human delivery or safety data.
Simplified
Key numbers
20×
Increase in (HeLa cells)
vs. at 200 ng dose
10×
Increase in (HEK293T cells)
vs. at 200 ng dose
>50-fold
Muscle-to-Liver Ratio
Muscle transfection vs. liver transfection after intramuscular injection of
mRNA Technology